Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 25, 2019 Off

BIO Applauds Enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act

By BusinessWire

Legislation will strengthen pipeline of medical countermeasures against serious public health threats WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) today applauds…

June 25, 2019 Off

Innovest Global Shareholder Update: Growth, Large Bids, Streamlined Operations and Acquisition Pipeline

By BusinessWire

First Quarter 2019 Revenue $11.7 Million is 1,565% sales growth over Q1 2018, Second Quarter Results Expected to Maintain First…

June 25, 2019 Off

PharmaCyte Biotech Releases New Interviews from Austrianova’s GMP Facility on Company’s Website

By BusinessWire

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for…

June 25, 2019 Off

Real-World Data Capabilities: Benchmarking Pharma Companies (2019) Featuring Concerto HealthAI, IMI Harmony, J&J, Pfizer, Sanofi, and Teva

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Real-World Data Capabilities: Benchmarking Pharma Companies (2019)” report has been added to ResearchAndMarkets.com’s offering. Are you fully and…

Sumitomo Dainippon Pharma Adopts Veeva Vault RIM to Streamline Global Regulatory Submissions
June 25, 2019 Off

Sumitomo Dainippon Pharma Adopts Veeva Vault RIM to Streamline Global Regulatory Submissions

By BusinessWire

Leading Japanese pharmaceutical company standardizes on Vault Submissions and Vault Submissions Archive to speed submission development and health authority correspondence

Aldeyra Therapeutics Announces Results from the SOLACE Trial in Noninfectious Anterior Uveitis
June 25, 2019 Off

Aldeyra Therapeutics Announces Results from the SOLACE Trial in Noninfectious Anterior Uveitis

By BusinessWire

Statistical Significance Not Achieved for Primary or Secondary Endpoints Due to High Rates of Disease Resolution in Vehicle-Treated Patients, but Activity of Reproxalap Observed to be Consistently Greater than Vehicle

June 25, 2019 Off

$175 Bn Bio-Decontamination (Equipment, Service, Consumables) Market – Global Forecast to 2024

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Bio Decontamination Market by Product (Equipment, Service, Consumables), Agent (Hydrogen Peroxide, Chlorine, Nitrogen, Peracetic Acid), Type, End User…

June 25, 2019 Off

Tricida Announces Publication of Positive Long-Term Phase 3 Clinical Trial Results of Veverimer (TRC101) in The Lancet

By BusinessWire

TRCA-301E trial is the first, long-term, randomized, multicenter, blinded, placebo-controlled trial to evaluate the treatment of metabolic acidosis in patients…

June 25, 2019 Off

Medison Establishes Canada’s Only Innovative Pharma Commercial Company

By BusinessWire

Joe O’Neill Announced as General Manager of Medison Canada PETACH TIKVA, Israel–(BUSINESS WIRE)–Medison Biotech (1995) Ltd. (“Medison”), today announced the…

June 25, 2019 Off

Generation Bio Appoints Katherine Fitzgerald, Ph.D., to its Scientific Advisory Board

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Generation Bio, a company developing the first genetic medicines that can be re-dosed and titrated to effect for…

Posts pagination

Previous 1 … 3,048 3,049 3,050 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine